These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 14620847)

  • 1. Expectations for process validation: industry perspectives.
    Francis R
    Dev Biol (Basel); 2003; 113():9-14. PubMed ID: 14620847
    [No Abstract]   [Full Text] [Related]  

  • 2. Canadian perspectives on expectations for process validation.
    Ridgway A
    Dev Biol (Basel); 2003; 113():3-8. PubMed ID: 14620846
    [No Abstract]   [Full Text] [Related]  

  • 3. The other side of process validation.
    Agalloco JP
    J Parenter Sci Technol; 1986; 40(6):251-2. PubMed ID: 3819977
    [No Abstract]   [Full Text] [Related]  

  • 4. Quality: an old solution to new discovery dilemmas?
    Volsen SG; Kent JM; Masson M
    Drug Discov Today; 2004 Nov; 9(21):903-5. PubMed ID: 15501718
    [No Abstract]   [Full Text] [Related]  

  • 5. [Standards of good production. Problems of sampling].
    Fontani F; Sekules G; Zanotti Gerosa A
    Boll Chim Farm; 1975 Feb; 114(2):57-69. PubMed ID: 1203102
    [No Abstract]   [Full Text] [Related]  

  • 6. Experience with validation of clinical trial materials: an inspector's viewpoint.
    Wolfe L
    Dev Biol (Basel); 2003; 113():27-33. PubMed ID: 14620849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Standards of good production. Human and technical aspects].
    Rocchi B
    Boll Chim Farm; 1975 Jan; 114(1):3-9. PubMed ID: 1203097
    [No Abstract]   [Full Text] [Related]  

  • 8. Regulatory and quality considerations for continuous manufacturing. May 20-21, 2014 Continuous Manufacturing Symposium.
    Allison G; Cain YT; Cooney C; Garcia T; Bizjak TG; Holte O; Jagota N; Komas B; Korakianiti E; Kourti D; Madurawe R; Morefield E; Montgomery F; Nasr M; Randolph W; Robert JL; Rudd D; Zezza D
    J Pharm Sci; 2015 Mar; 104(3):803-12. PubMed ID: 25830179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving drug manufacturing with process analytical technology.
    Rodrigues LO; Alves TP; Cardoso JP; Menezes JC
    IDrugs; 2006 Jan; 9(1):44-8. PubMed ID: 16374733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Organic solvents in the pharmaceutical industry.
    Grodowska K; Parczewski A
    Acta Pol Pharm; 2010; 67(1):3-12. PubMed ID: 20210074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A practical approach to supplier quality improvement.
    O'Riordan L
    J Parenter Sci Technol; 1991; 45(1):29-40. PubMed ID: 2007967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Guidelines for introducing new drugs for medical use in Poland and control of their quality].
    Danysz A
    Pol Tyg Lek; 1984 Dec 17-31; 39(51-52):1673-4. PubMed ID: 6522321
    [No Abstract]   [Full Text] [Related]  

  • 13. Statistical tools for setting in-process acceptance criteria.
    Seely RJ; Munyakazi L; Haury J
    Dev Biol (Basel); 2003; 113():17-25. PubMed ID: 14620848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Site transfer and process validation in case of Herceptin API.
    Kuhne W
    Dev Biol (Basel); 2003; 113():47-50. PubMed ID: 14620851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Maintaining standards of good compounding (N.B.F.)].
    Castoldi B; Fumagalli A; Mazzoldi G
    Boll Chim Farm; 1978 Dec; 117(12):689-99. PubMed ID: 752351
    [No Abstract]   [Full Text] [Related]  

  • 16. Validation of fermentation processes.
    Lubiniecki AS; Gardner AR; Smith TM; Wang WK; McAllister PR; Federici MM
    Dev Biol (Basel); 2003; 113():37-44; discussion 111-2. PubMed ID: 14620850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Re-processing of biological products: regulatory considerations from the CBER perspective.
    Shacter E
    Dev Biol (Basel); 2003; 113():105-7; discussion 115-6. PubMed ID: 14620859
    [No Abstract]   [Full Text] [Related]  

  • 18. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organ Tech Rep Ser; 2008; (948):1-138. PubMed ID: 18557474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [For the increase of qualification of engineering cadres for the chemical and pharmaceutical industry].
    Blazek J
    Cesk Farm; 1974 Dec; 23(10):397-9. PubMed ID: 4455399
    [No Abstract]   [Full Text] [Related]  

  • 20. Validation, risk-benefit analysis.
    Kieffer RG
    PDA J Pharm Sci Technol; 1995; 49(5):249-52. PubMed ID: 7489200
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.